Trader Note — 2287 total
ELA just delivered one of its biggest earnings surprises in recent memory, and the stock heads into the rest of May with a genuinely unusual setup: a blowout print, fading short interest, and options that are no longer…
Curtiss-Wright enters its May 7 Q1 earnings call having done something its options market hadn't managed in months: turned decisively bullish. The clearest setup this week is in options. The put/call ratio dropped to…
Costco Wholesale enters its fiscal Q3 earnings window — results due May 28 — trading near $1,016, up 2.3% on the week and essentially flat over the past month. The tension this week is not in short positioning, which…
CoreCivic reported Q1 2026 earnings after the close on Wednesday, posting FFO of $0.65 against a $0.55 consensus estimate and revenue of $614.7 million versus the $604.5 million expected. Management lifted full-year…
CGNX heads into its Q1 earnings call on May 7 with the stock up nearly 10% on the week and options sentiment at its most bullish reading of the year. The options signal is the standout this week. The put/call ratio has…
Coca-Cola Consolidated heads into its May 8 earnings report with the stock up sharply and options traders as defensively positioned as they've been all year. The price tells a straightforward story. Shares climbed 7.2%…
Cirrus Logic enters the week after its earnings report trading at $171.22 — up 5.4% on the week and 16% over the past month — yet options traders have quietly pivoted toward downside protection even as the stock…
LUMN enters the post-earnings window carrying two conflicting signals: a Q1 loss that missed estimates by $0.34 per share and a $475 million acquisition of cloud networking firm Alkira that management is billing as the…
Central Garden & Pet just delivered its best quarterly result on record — and the market went cold on it almost immediately. The company reported Q2 fiscal 2026 adjusted EPS of $1.29, well clear of the $1.10 consensus…
Carriage Services enters its Q1 2026 earnings call — scheduled for Thursday May 7 — with a week that told two different stories at once. The clearest shift this week is in options positioning. The put/call ratio has…
CSG Systems International heads into the week with short sellers having sharply reduced their positions over the past month — yet the stock remains one of the more heavily shorted mid-cap names in its peer group, and…
H&R Block reported Q3 fiscal 2026 results after the close on May 6 that directly contradict the bear thesis that has been building all month — and the stock's pre-earnings slide makes the setup all the more…
Black Hills Corporation heads into its Q1 earnings report tomorrow with short sellers at their most aggressive in months — yet the stock's options market is telling a calmer story. Short interest has jumped sharply…
Barrett Business Services enters the week with an unusual combination: insiders buying aggressively into weakness while short sellers are heading for the exit. The insider story is the standout here. CEO Gary Kramer…
ATN International just reported Q1 2026 results with the earnings call due May 7 — and the headline is a clean miss paired with a reaffirmed full-year outlook. The tension going into this print was already…
American Vanguard just reported its best quarterly surprise in recent memory — and the stock is still trading at $2.95. Q1 2026 results landed after the close on May 6, with sales of $123.6 million beating the year-ago…
AWR reported Q1 2026 results on May 6, just after the close — and the setup heading into the number was already complicated. The stock dropped 4.1% on the week to $76.20, slightly worse than close peers, arriving at…
OSG heads into its Q1 2026 earnings call on May 7 having just delivered a blowout result, yet the stock has given back ground over the past week — a tension that makes the call itself the event to watch. Octave…
ADBE enters the week of May 6 carrying an unusual tension: the stock has clawed back 5% over the past week to $255.62, yet the analyst community has been trimming targets and pulling ratings for the better part of six…
Sarepta Therapeutics just delivered one of the most dramatic earnings beats in its recent history — and yet the short position barely flinched. Q1 adjusted EPS of $3.16 demolished the $0.99 consensus estimate by more…
